Lobbying

Pinnacle Treatment Centers's latest lobbying report covers Q2 2026, at $20K. The four quarters Q4 2025–Q3 2026 total $90K. Its first report covers Q4 2022; the issues it reports most are Health Issues.

Pinnacle Treatment Centers

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$90K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Pinnacle Treatment Centers lobbying by quarter
Pinnacle Treatment Centers lobbying by quarter
QuarterAmountReports
Q4 2022$10K1
Q1 2023$20K1
Q2 2023$70K1
Q3 2023$10K1
Q4 2023$40K1
Q1 2024$60K1
Q2 2024$60K1
Q3 2024$20K1
Q4 2024$20K1
Q1 2025$50K1
Q2 2025$60K1
Q3 2025$10K1
Q4 2025$10K1
Q1 2026$60K1
Q2 2026$20K1
Q3 2026$00

By issue

  • Health issues$520K · 15 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES13 reports
  • SENATE9 reports
  • Substance Abuse & Mental Health Services Administration (SAMHSA)4 reports
  • Health & Human Services, Dept of (HHS)2 reports
  • Centers For Medicare and Medicaid Services (CMS)1 reports
  • Executive Office of the President (EOP)1 reports
  • Office of Natl Drug Control Policy (NDCP)1 reports
  • White House Office1 reports

Firms it paid

Firm
K&L Gates$520K15 quarters

Former officials lobbying for it

Former position
SCOTT J. GELBMANStaff Asst/Leg Corr/Leg Asst, Sen Chuck SchumerQ1 2026
MICHAEL DOYLEU.S. CongressmanQ1 2024

Lobbying reports

Filed by
07/20for Q2K&L Gates$20K
04/18for Q1K&L Gates$60K
01/19for Q4 2025K&L Gates$10K
25/10/20for Q3 2025K&L Gates$10K
25/07/19for Q2 2025K&L Gates$60K
25/04/19for Q1 2025K&L Gates$50K
25/01/19for Q4 2024K&L Gates$20K
24/10/17for Q3 2024K&L Gates$20K
24/07/14for Q2 2024K&L Gates$60K
24/04/17for Q1 2024K&L Gates$60K
24/01/18for Q4 2023K&L Gates$40K
23/10/15for Q3 2023K&L Gates$10K
23/07/17for Q2 2023K&L Gates$70K
23/04/18for Q1 2023K&L Gates$20K
23/01/15for Q4 2022K&L Gates$10K